Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?
Autor: | Goldmann, Luise, Duan, Rundan, Kragh, Thorsten, Wittmann, Georg, Weber, Christian, Lorenz, Reinhard, von Hundelshausen, Philipp, Spannagl, Michael, Siess, Wolfgang |
---|---|
Zdroj: | In Blood Advances 10 December 2019 3(23):4021-4033 |
Databáze: | ScienceDirect |
Externí odkaz: |